| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Cell Sciences, Tsukuba Institute, RIKEN, Koyadai, Tsukuba, Ibaraki 305-0074, Japan (J.S., Y.S., S.K.); Institute of Applied Biochemistry, University of Tsukuba, Tennoudai, Tsukuba, Ibaraki 305-0006, Japan (J.S., Y.S., P.-C.W., M.M.); and Laboratory of Cell Regulation and Carcinogenesis, Division of Basic Science, National Cancer Institute, National Institute of Health, Bethesda, Maryland 20892 (S.-J.K.)
Address all correspondence and requests for reprints to: Soichi Kojima, Ph.D., Laboratory of Molecular Cell Sciences, Tsukuba Institute, RIKEN, Koyadai, Tsukuba, Ibaraki 305-0074, Japan. E-mail: kojima{at}rtc.riken.go.jp
Modulation of Sp1 activity by nuclear receptors is a novel mechanism by which fat-soluble hormones regulate gene expression. We previously established that upon autoinduction of RARs by RA, RARs/RXRs physically interact with Sp1, potentiate Sp1 binding to the GC box motifs, and thus enhance transactivation of the urokinase promoter, which lacks a canonical RAR-responsive element/RXR-responsive element. Here, we examined whether a similar mechanism might participate in transcriptional regulation of other key RA-inducible genes in endothelial cells and characterized binding between Sp1 and GC box motifs. Northern blot analyses showed that in addition to urokinase, after induction of RARs, RA up-regulates GC-rich region-dependent mRNA expression of transglutaminase, TGFß1, and types I and II TGFß receptors. RA failed to alter the expression of Sp1 at both mRNA and protein levels. Reporter and gel shift assays and Western blot analyses suggested that either RA-treatment or RAR/RXR-overexpression enhances transactivation of these genes through a GC-rich region and strengthens the affinity of Sp1 to GC box motifs, accompanying a potential conformational change of Sp1 as reflected in its increased immunogenicity. Detailed analyses of the GC box motifs within the urokinase and other promoters indicate that interaction between RAR/RXR and Sp1 does not occur in the presence of nonfunctional GC box motifs containing five tandem purine or pyrimidine bases at the 3'-flanking region of hexanucleotide core sequence. These findings provide insight into the molecular mechanisms underlying RARE/RXRE-independent transactivation of RA-inducible gene promoters.
This article has been cited by other articles:
![]() |
Y.-H. Cheng, P. Yin, Q. Xue, B. Yilmaz, M. I. Dawson, and S. E. Bulun Retinoic Acid (RA) Regulates 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometrium: Interaction of RA Receptors with Specificity Protein (SP) 1/SP3 for Estradiol Metabolism J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1915 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. van Wageningen, M. C. Breems-de Ridder, J. Nigten, G. Nikoloski, C. A. J. Erpelinck-Verschueren, B. Lowenberg, T. de Witte, D. G. Tenen, B. A. van der Reijden, and J. H. Jansen Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RAR{alpha} Blood, February 1, 2008; 111(3): 1634 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, S.-Y. Cai, S. Xu, L. A. Denson, C. J. Soroka, and J. L. Boyer Nuclear receptors RXR{alpha}:RAR{alpha} are repressors for human MRP3 expression Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1221 - G1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Stoner, S. S. Auerbach, S. M. Zamule, S. C. Strom, and C. J. Omiecinski Transactivation of a DR-1 PPRE by a human constitutive androstane receptor variant expressed from internal protein translation start sites Nucleic Acids Res., April 1, 2007; 35(7): 2177 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Cheng, A. Imir, T. Suzuki, V. Fenkci, B. Yilmaz, H. Sasano, and S. E. Bulun SP1 and SP3 Mediate Progesterone-Dependent Induction of the 17beta Hydroxysteroid Dehydrogenase Type 2 Gene in Human Endometrium Biol Reprod, October 1, 2006; 75(4): 605 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Balajthy, K. Csomos, G. Vamosi, A. Szanto, M. Lanotte, and L. Fesus Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions Blood, September 15, 2006; 108(6): 2045 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, M. Dokmanovic, W. D. Stein, R. J. Ardecky, and I. B. Roninson Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells. Cancer Res., September 1, 2006; 66(17): 8749 - 8761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Passeri, A. Marcucci, G. Rizzo, M. Billi, M. Panigada, L. Leonardi, F. Tirone, and F. Grignani Btg2 enhances retinoic Acid-induced differentiation by modulating histone h4 methylation and acetylation. Mol. Cell. Biol., July 1, 2006; 26(13): 5023 - 5032. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P. Metz, and S. Safe Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17{beta}-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins Endocrinology, July 1, 2006; 147(7): 3285 - 3295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Monslow, J. D. Williams, D. J. Fraser, D. R. Michael, P. Foka, A. P. Kift-Morgan, D. D. Luo, C. A. Fielding, K. J. Craig, N. Topley, et al. Sp1 and Sp3 Mediate Constitutive Transcription of the Human Hyaluronan Synthase 2 Gene J. Biol. Chem., June 30, 2006; 281(26): 18043 - 18050. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qi and M. Ratnam Synergistic Induction of Folate Receptor {beta} by All-Trans Retinoic Acid and Histone Deacetylase Inhibitors in Acute Myelogenous Leukemia Cells: Mechanism and Utility in Enhancing Selective Growth Inhibition by Antifolates Cancer Res., June 1, 2006; 66(11): 5875 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Resendes and A. G. Rosmarin GA-Binding Protein and p300 Are Essential Components of a Retinoic Acid-Induced Enhanceosome in Myeloid Cells Mol. Cell. Biol., April 15, 2006; 26(8): 3060 - 3070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tabe, M. Konopleva, R. Contractor, M. Munsell, W. D. Schober, L. Jin, Y. Tsutsumi-Ishii, I. Nagaoka, J. Igari, and M. Andreeff Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells Blood, February 15, 2006; 107(4): 1546 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, R. Barhoumi, R. Burghardt, and S. Safe Analysis of Estrogen Receptor {alpha}-Sp1 Interactions in Breast Cancer Cells by Fluorescence Resonance Energy Transfer Mol. Endocrinol., April 1, 2005; 19(4): 843 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Marin, G. Esteban-Pretel, R. Alonso, Y. Sado, T. Barber, J. Renau-Piqueras, and J. Timoneda Vitamin A Deficiency Alters the Structure and Collagen IV Composition of Rat Renal Basement Membranes J. Nutr., April 1, 2005; 135(4): 695 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Wolf, R. L. Medcalf, and C. Jern The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid Blood, February 1, 2005; 105(3): 1060 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sato, T. Tanaka, K. Maemura, T. Uchiyama, H. Sato, T. Maeno, T. Suga, T. Iso, Y. Ohyama, M. Arai, et al. The PAI-1 Gene as a Direct Target of Endothelial PAS Domain Protein-1 in Adenocarcinoma A549 Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Abrams, J. Xu, C. Nativelle-Serpentini, S. Dabirshahsahebi, and M. B. Rogers An Evolutionary and Molecular Analysis of Bmp2 Expression J. Biol. Chem., April 16, 2004; 279(16): 15916 - 15928. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hao, H. Qi, and M. Ratnam Modulation of the folate receptor type {beta} gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites Blood, June 1, 2003; 101(11): 4551 - 4560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abdelrahim, I. Samudio, R. Smith III, R. Burghardt, and S. Safe Small Inhibitory RNA Duplexes for Sp1 mRNA Block Basal and Estrogen-induced Gene Expression and Cell Cycle Progression in MCF-7 Breast Cancer Cells J. Biol. Chem., August 2, 2002; 277(32): 28815 - 28822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |